Omidria FDA Approval History
FDA Approved: Yes (First approved May 30, 2014)
Brand name: Omidria
Generic name: ketorolac and phenylephrine
Dosage form: Injection
Company: Omeros Corporation
Treatment for: Intraocular Lens Replacement Procedures
Omidria (ketorolac and phenylephrine) is an anti-inflammatory and mydriatic combination added to irrigation solution during cataract surgery and intraocular lens replacement procedures.
Development timeline for Omidria
| Date | Article |
|---|---|
| Dec 12, 2017 | Approval Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients |
| Jun 2, 2014 | Approval FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.